Patrys has today announced the retirement of Ms Suzy Jones as a Director of Patrys effective from close of business on Friday, 15 September 2023.
Ms Jones joined the Patrys Board in 2011 and has played a pivotal role in the Company’s evolution over the last decade. Her corporate strategy, drug development and business development guidance helped Patrys gain access to novel technologies and expand its portfolio.
Patrys Chief Executive Officer and Managing Director, Dr. James Campbell said:
“Suzy has been an outstanding director of Patrys and brought formidable intellect and insight to the governance and oversight of our Company. On behalf of the Board, I would like to extend my immense thanks to Suzy and wish her every success in her future endeavours.”
Patrys has now commenced searching for a new Non-Executive Director to help contribute to its next phase of growth as it becomes a clinical-stage therapeutic development company.